Document is current
Any future updates will be listed below
-
Authors
Di Sabatino, Elena
Ferraro, Diana
Gaetani, Lorenzo
Emiliano, Edoardo
Parnetti, Lucilla
Di Filippo, Massimiliano https://orcid.org/0000-0002-2645-7477
-
Funding
Funding for this research was provided by:
Università degli Studi di Perugia
- License Information
-
More Information
Article History
Received: 27 October 2024
Revised: 4 January 2025
Accepted: 7 January 2025
First Online: 17 February 2025
Declarations
:
: EDS received travel grants and/or speaker honoraria from Alexion, Almirall, Biogen, Bristol-Myers Squibb, Horizon, Novartis, Roche, Sanofi, and Viatris. DF has received travel grants and/or fees for speaking and/or advisory boards from Alexion, Binding Site, Biogen, Bristol-Myers Squibb, Celgene, Merck, Novartis, Roche, and Sanofi. EE received travel grants from Biogen and Janssen. LG participated on advisory boards for, and received speaker or writing honoraria and travel grants from Almirall, Biogen, Euroimmun, Fujirebio, Lilly, Merck, Mylan, Novartis, Roche, Sanofi, Siemens Healthineers, and Teva. MDF participated on advisory boards and steering committees for and received speaker or writing honoraria, research support and funding for travelling from Alexion, Amgen, BMS, Bayer, Biogen Idec, Genzyme, Horizon, Janssen, Merck, Mylan, Novartis, Roche, Siemens Healthineers, Teva and Viatris. LP reports no conflict of interest.
